Outset Medical

Outset Medical is a public medical device company on a mission to disrupt the stagnant, high-cost dialysis market through its integrated Tablo Hemodialysis System. Its core strategy targets two key segments: enabling hospitals to insource acute dialysis services to improve economics and control, and empowering patients to adopt home hemodialysis through a simplified platform. The company has achieved significant commercial traction, with nearly 1,000 hospitals adopting Tablo, and is backed by a growing body of clinical evidence demonstrating improved patient symptoms, training efficiency, and clinical versatility.

The Tablo Hemodialysis System is an all-in-one, integrated platform that performs on-demand water purification and dialysate generation within a single console, eliminating the need for external water treatment infrastructure. It is digitally connected via the Outset Connect cloud platform for data analytics and EMR integration.

Outset competes against the service model of Large Dialysis Organizations (LDOs) in acute care and against traditional HHD machine manufacturers (Fresenius, Baxter) in the home. Its primary competitive advantages are Tablo's integrated, infrastructure-free design and its data-connected platform, which simplify operations across care settings.